Lista de obras -

A Role for Virally Induced Reactive Oxygen Species in Kaposi's Sarcoma Herpesvirus Tumorigenesis ⬇️

artículo científico publicado el 20 de agosto de 2012

A role of hypoxia-inducible factor 1 alpha in Murine Gammaherpesvirus 68 (MHV68) lytic replication and reactivation from latency

artículo científico publicado en 2019

Activation of the unfolded protein response by 2-deoxy-D-glucose inhibits Kaposi's sarcoma-associated herpesvirus replication and gene expression

artículo científico publicado en 2012

Antitumorigenesis of antioxidants in a transgenic Rac1 model of Kaposi's sarcoma

artículo científico publicado en 2009

CD30 targeting with brentuximab vedotin: a novel therapeutic approach to primary effusion lymphoma

artículo científico publicado en 2013

Copper deficiency induced by tetrathiomolybdate suppresses tumor growth and angiogenesis.

artículo científico publicado en 2002

Disrupting galectin-1 interactions with N-glycans suppresses hypoxia-driven angiogenesis and tumorigenesis in Kaposi's sarcoma

artículo científico publicado en 2012

Efficacious proteasome/HDAC inhibitor combination therapy for primary effusion lymphoma

artículo científico publicado en 2013

Efficacy of bortezomib in a direct xenograft model of primary effusion lymphoma

artículo científico publicado en 2010

G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator

artículo científico publicado en 1998

Glycosylation-dependent lectin-receptor interactions preserve angiogenesis in anti-VEGF refractory tumors

artículo científico publicado en 2014

High-throughput sequencing analysis of a "hit and run" cell and animal model of KSHV tumorigenesis

scientific article published on 30 June 2020

Human viral oncogenesis: a cancer hallmarks analysis

artículo científico publicado en 2014

In Vivo-Restricted and Reversible Malignancy Induced by Human Herpesvirus-8 KSHV: A Cell and Animal Model of Virally Induced Kaposi's Sarcoma

In vivo-restricted and reversible malignancy induced by human herpesvirus-8 KSHV: a cell and animal model of virally induced Kaposi's sarcoma.

artículo científico publicado en 2007

In vivoElectroporation and Non-protein Based Screening Assays to Identify Antibodies Against Native Protein Conformations ⬇️

artículo científico publicado el 1 de octubre de 2011

KSHV G-protein coupled receptor vGPCR oncogenic signaling upregulation of Cyclooxygenase-2 expression mediates angiogenesis and tumorigenesis in Kaposi's sarcoma

scientific article published on 15 October 2020

KSHV-induced ligand mediated activation of PDGF receptor-alpha drives Kaposi's sarcomagenesis

scientific article published on 09 July 2018

KSHV-mediated ROS induction defines novel therapeutic targets in Kaposi’s sarcoma.

artículo científico publicado en 2010

Kaposi's Sarcoma Herpesvirus Oncogenesis Is a Notch Better in 3D ⬇️

artículo científico publicado el 15 de diciembre de 2011

Kaposi's Sarcoma-Associated Herpesvirus-Encoded Viral IL-6 (vIL-6) Enhances Immunoglobulin Class-Switch Recombination

scientific article published in 2018

Kaposi's sarcoma and its associated herpesvirus ⬇️

artículo científico publicado el 1 de octubre de 2010

Kaposi's sarcoma associated herpesvirus G protein-coupled receptor immortalizes human endothelial cells by activation of the VEGF receptor-2/ KDR.

artículo científico publicado en 2003

Massive Secretion by T Cells Is Caused by HIV Nef in Infected Cells and by Nef Transfer to Bystander Cells

article

Molecular and cellular mechanisms of KSHV oncogenesis of Kaposi's sarcoma associated with HIV/AIDS

artículo científico publicado en 2014

Molecular studies and therapeutic targeting of Kaposi's sarcoma herpesvirus (KSHV/HHV-8) oncogenesis

artículo científico publicado en 2013

Novel alkynylphosphonate analogue of calcitriol with potent antiproliferative effects in cancer cells and lack of calcemic activity

artículo científico publicado en 2011

PDGFRA defines the mesenchymal stem cell Kaposi's sarcoma progenitors by enabling KSHV oncogenesis in an angiogenic environment

artículo científico publicado en 2019

Pathogenesis of viral lymphomas.

artículo científico publicado en 2006

Productively infected murine Kaposi's sarcoma-like tumors define new animal models for studying and targeting KSHV oncogenesis and replication

artículo científico publicado en 2014

Unbiased Screening of Activated Receptor Tyrosine Kinases (RTKs) in Tumor Extracts Using a Mouse Phospho-RTK Array Kit

scientific article published on 01 April 2019

Lista de obras de

A Role for Virally Induced Reactive Oxygen Species in Kaposi's Sarcoma Herpesvirus Tumorigenesis ⬇️

A role of hypoxia-inducible factor 1 alpha in Murine Gammaherpesvirus 68 (MHV68) lytic replication and reactivation from latency

Activation of the unfolded protein response by 2-deoxy-D-glucose inhibits Kaposi's sarcoma-associated herpesvirus replication and gene expression

Antitumorigenesis of antioxidants in a transgenic Rac1 model of Kaposi's sarcoma

CD30 targeting with brentuximab vedotin: a novel therapeutic approach to primary effusion lymphoma

Copper deficiency induced by tetrathiomolybdate suppresses tumor growth and angiogenesis.

Disrupting galectin-1 interactions with N-glycans suppresses hypoxia-driven angiogenesis and tumorigenesis in Kaposi's sarcoma

Efficacious proteasome/HDAC inhibitor combination therapy for primary effusion lymphoma

Efficacy of bortezomib in a direct xenograft model of primary effusion lymphoma

G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator

Glycosylation-dependent lectin-receptor interactions preserve angiogenesis in anti-VEGF refractory tumors

High-throughput sequencing analysis of a "hit and run" cell and animal model of KSHV tumorigenesis

Human viral oncogenesis: a cancer hallmarks analysis

In Vivo-Restricted and Reversible Malignancy Induced by Human Herpesvirus-8 KSHV: A Cell and Animal Model of Virally Induced Kaposi's Sarcoma

In vivo-restricted and reversible malignancy induced by human herpesvirus-8 KSHV: a cell and animal model of virally induced Kaposi's sarcoma.

In vivoElectroporation and Non-protein Based Screening Assays to Identify Antibodies Against Native Protein Conformations ⬇️

KSHV G-protein coupled receptor vGPCR oncogenic signaling upregulation of Cyclooxygenase-2 expression mediates angiogenesis and tumorigenesis in Kaposi's sarcoma

KSHV-induced ligand mediated activation of PDGF receptor-alpha drives Kaposi's sarcomagenesis

KSHV-mediated ROS induction defines novel therapeutic targets in Kaposi’s sarcoma.

Kaposi's Sarcoma Herpesvirus Oncogenesis Is a Notch Better in 3D ⬇️

Kaposi's Sarcoma-Associated Herpesvirus-Encoded Viral IL-6 (vIL-6) Enhances Immunoglobulin Class-Switch Recombination

Kaposi's sarcoma and its associated herpesvirus ⬇️

Kaposi's sarcoma associated herpesvirus G protein-coupled receptor immortalizes human endothelial cells by activation of the VEGF receptor-2/ KDR.

Massive Secretion by T Cells Is Caused by HIV Nef in Infected Cells and by Nef Transfer to Bystander Cells

Molecular and cellular mechanisms of KSHV oncogenesis of Kaposi's sarcoma associated with HIV/AIDS

Molecular studies and therapeutic targeting of Kaposi's sarcoma herpesvirus (KSHV/HHV-8) oncogenesis

Novel alkynylphosphonate analogue of calcitriol with potent antiproliferative effects in cancer cells and lack of calcemic activity

PDGFRA defines the mesenchymal stem cell Kaposi's sarcoma progenitors by enabling KSHV oncogenesis in an angiogenic environment

Pathogenesis of viral lymphomas.

Productively infected murine Kaposi's sarcoma-like tumors define new animal models for studying and targeting KSHV oncogenesis and replication

Unbiased Screening of Activated Receptor Tyrosine Kinases (RTKs) in Tumor Extracts Using a Mouse Phospho-RTK Array Kit